| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
22- hydroximino- 23,24- bisnor- 4- cholen- 3- one
1
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: inhibits androgen synthesis; structure given in first source
Also Known As:23,24-bisnor-4-cholen-3,22-dione 22-oxime; HBNCO
Bio-Agent Context: Research Results
Related Diseases
| 1. | Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/01/1995
- "The 22-hydroximino-23,24-bisnor-4-cholen-3-one (22-oxime) was synthesized and evaluated as an inhibitor of 17 alpha-hydroxylase/C17,20-lyase in rat testicular microsomes and the 5 alpha-reducatase of human prostatic microsomes from patients with benign prostatic hypertrophy"
Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
Related Drugs and Biologics
| 1. | Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)
|
| 1 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License details >>
| Price: | $490.00 access via web interface, 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |